The aberrant activation of GLI1 has been linked to the promotion of oncogenic activities such as metastasis, DNA damage repair, stemness, and chemotherapeutic resistance in various cancers such as glioma, pancreatic cancer, and colorectal cancer. This evidence concerns the gene GLI1 and central nervous system cancer.